跳至主要内容
临床试验/NCT06175650
NCT06175650招募中不适用

Towards a Sex-specific "Female Enhanced Recovery After Cardiac Surgery'' (F-ERAS) Pathway: An Observational Registration and Evaluation of Characteristics and Perioperative Management of Cardiac Surgery Patients

Jennifer Breel1 个研究点 分布在 1 个国家目标入组 5,500 人开始时间: 2023年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
5,500
试验地点
1
主要终点
Primary endpoint

研究概览

简要总结

The aim of this study is to evaluate the differences between men and women undergoing cardiac surgery. We will look at perioperative factors such as body weight, body surface area, previous medical history, pharmacokinetics, transfusion, coagulation, cardiopulmonary bypass (CPB) related factors, cardiac function, inotropic requirements, risk, and outcome scores as well as morbidity and mortality at 30 and 90 days, 1, 5, and 10 years.

详细描述

Observational, multicentre, retrospective data collection from the mandatory Quality Assurance database (the Netherlands Heart Registry, (NHR), supplemented with data from the electronic patient files (EPIC). The retrospective data is already available.

In addition, we will continue the retrospective study into a prospective registry of data after the analysis of the retrospective data. Patients will be approached one, five and ten years after the operation and a questionnaire will be sent to document quality of life. No research-related interventions other than questionnaires will be performed

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18 years
  • All patients who underwent cardiac surgery from 1 January 2016 to the start of the study, in either of the centres (AMC or VUmc) (retrospective)
  • All patients undergoing cardiac surgery from the start of the study (~March 2022) until approximately 2032

排除标准

  • Patients who object to the re-use of their care data or do not give consent

结局指标

主要结局

Primary endpoint

时间窗: up to 30 days post-surgery

Number of specific (coagulation), transfusion products,

Primary outcome

时间窗: up to 30 days post-surgery or if still in hospital, until discharge

Times: surgical, cross-clamp, bypass, anesthetic, intensive care admission, hospital admission, etc.

次要结局

  • Health related Quality of life measured by PROMS(At 1, 5 and 10 years)
  • Morbidity and mortality(At 30, 90, 365 days)
  • Survival(At 5 and 10 years)

研究者

发起方
Jennifer Breel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jennifer Breel

Investigator

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

研究点 (1)

Loading locations...

相似试验